Claims runout is the actuarial lag at the center of managed care reporting: provider invoices for services rendered in a given quarter continue arriving for weeks after that period closes, and any company bearing medical cost risk must estimate how much expense has been incurred but not yet billed. The uncertainty that creates is not uniform across patient populations. Organizations managing people with complex conditions tend to see higher claim frequency and larger average episode cost, both of which stretch the runout tail and add variance to the reported figures. Against that backdrop, Evolent Health, Inc. (NYSE: EVH), a Washington-based company focused on achieving better health outcomes for people with complex conditions, announced July 8, 2026, that it will publish second quarter 2026 financial results on Thursday, August 6, 2026, before market open.
The pre-market release and price discovery
A before-open publication concentrates price discovery at the regular market open rather than fragmenting it across extended hours, where volume is thin and spreads can exaggerate moves in either direction. The August 6 date lands Evolent's Q2 disclosure in the back half of the standard summer earnings season.
What the July 8 announcement covers
The press release, distributed via PRNewswire from Washington, is a calendar notice confirming the reporting date and pre-market timing. Evolent Health trades on the New York Stock Exchange under the ticker EVH. Full second quarter results, covering the period ending June 30, 2026, reach investors before the opening bell on August 6.